These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2402739)

  • 1. The increased rate of activation of factor XII in late pregnancy can contribute to the increased reactivity of factor VII.
    Mitropoulos KA; Martin JC; Burgess AI; Esnouf MP; Stirling Y; Howarth DJ; Reeves BE
    Thromb Haemost; 1990 Jun; 63(3):349-55. PubMed ID: 2402739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of factors XII and VII induced in citrated plasma in the presence of contact surface.
    Mitropoulos KA; Martin JC; Stirling Y; Morrisey JH; Cooper JA
    Thromb Res; 1995 Apr; 78(1):67-75. PubMed ID: 7778067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between factor VII coagulant activity and factor XII activation induced in plasma by endogenous or exogenously added contact surface.
    Mitropoulos KA; Reeves BE; O'Brien DP; Cooper JA; Martin JC
    Blood Coagul Fibrinolysis; 1993 Apr; 4(2):223-34. PubMed ID: 8499561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal antibody raised against human beta-factor XIIa which also recognizes alpha-factor XIIa but not factor XII or complexes of factor XIIa with C1 esterase inhibitor.
    Esnouf MP; Burgess AI; Dodds AW; Sarphie AF; Miller GJ
    Thromb Haemost; 2000 Jun; 83(6):874-81. PubMed ID: 10896241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibodies may impair factor XIIa-dependent activation of fibrinolysis in pregnancy: in vitro evidence with human endothelial cells in culture and monoclonal anticardiolipin antibodies.
    Lázaro I; Carmona F; Reverter JC; Cervera R; Tassies D; Balasch J
    Am J Obstet Gynecol; 2009 Jul; 201(1):87.e1-6. PubMed ID: 19427615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activation of the contact phase of coagulation by physiologic surfaces in plasma: the effect of large negatively charged liposomal vesicles.
    Mitropoulos KA; Martin JC; Reeves BE; Esnouf MP
    Blood; 1989 May; 73(6):1525-33. PubMed ID: 2713491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor.
    Czendlik C; Lämmle B; Duckert F
    Thromb Haemost; 1985 Apr; 53(2):242-4. PubMed ID: 2410997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XIIa is a kinetically favorable plasminogen activator.
    Schousboe I; Feddersen K; Røjkjaer R
    Thromb Haemost; 1999 Sep; 82(3):1041-6. PubMed ID: 10494761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA
    Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-1 inactivator and cold-promoted activation of factor VII.
    van Royen EA; Lohman S; Voss M; Pondman KW
    J Lab Clin Med; 1978 Aug; 92(2):152-63. PubMed ID: 681808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulation of human factor XIIa by plasma proteinase inhibitors.
    Pixley RA; Schapira M; Colman RW
    J Biol Chem; 1985 Feb; 260(3):1723-9. PubMed ID: 2578463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated factor XII levels are dependent on factor XII 46C/T genotypes and factor XII zymogen levels, and are associated with vascular risk factors in patients and healthy subjects.
    Ishii K; Oguchi S; Murata M; Mitsuyoshi Y; Takeshita E; Ito D; Tanahashi N; Fukuuchi Y; Oosumi K; Matsumoto K; Kitajima M; Yamamoto M; Watanabe G; Ikeda Y; Watanabe K
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):277-84. PubMed ID: 10870808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitors.
    Derkx FH; Bouma BN; Schalekamp MA
    J Lab Clin Med; 1984 Apr; 103(4):560-73. PubMed ID: 6366096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cold enhancement of blood coagulation: observations on the role of C1(-)-inhibitor.
    Donaldson VH
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():41-7. PubMed ID: 6587742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemfibrozil reduces thrombin generation in patients with combined hyperlipidaemia, without influencing plasma fibrinogen, fibrin gel structure or coagulation factor VII.
    Bröijersén A; Hamsten A; Silveira A; Fatah K; Goodall AH; Eriksson M; Angelin B; Hjemdahl P
    Thromb Haemost; 1996 Aug; 76(2):171-6. PubMed ID: 8865525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activation of factor VII in citrated plasma by charged long-chain saturated fatty acids at the interface of large triglyceride-rich lipoproteins.
    Mitropoulos KA; Reeves BE; Miller GJ
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):943-51. PubMed ID: 8148488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal study on activated factors XII and VII levels during normal pregnancy.
    de Moerloose P; Amiral J; Vissac AM; Reber G
    Br J Haematol; 1998 Jan; 100(1):40-4. PubMed ID: 9450788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired factor XIIa-dependent activation of fibrinolysis in treated antiphospholipid syndrome gestations developing late-pregnancy complications.
    Carmona F; Lázaro I; Reverter JC; Tàssies D; Font J; Cervera R; Balasch J
    Am J Obstet Gynecol; 2006 Feb; 194(2):457-65. PubMed ID: 16458646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study.
    Miller GJ; Stirling Y; Esnouf MP; Heinrich J; van de Loo J; Kienast J; Wu KK; Morrissey JH; Meade TW; Martin JC
    Thromb Haemost; 1994 Jan; 71(1):38-48. PubMed ID: 8165645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.